The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Autophagy in tumour immunity and therapy
Open accessAbstract
Autophagy is a regulated mechanism that removes unnecessary or dysfunctional cellular components and recycles metabolic substrates. In response to stress signals in the tumour microenvironment, the autophagy pathway is altered in tumour cells and immune cells — thereby differentially affecting tumour progression, immunity and therapy. In this Review, we summarize our current understanding of the immunologically associated roles and modes of action of the autophagy pathway in cancer progression and therapy, and discuss potential approaches targeting autophagy to enhance antitumour immunity and improve the efficacy of current cancer therapy. Autophagy is induced by stress signals in cancer cells as well as immune cells in the tumour microenvironment. This Review discusses how autophagy modulates antitumour immunity in cancer cell autonomous and non-autonomous ways, and potential approaches for targeting autophagy to enhance the antitumour immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–206 of 206
Braña, I., Ocaña, A., Chen, E. X., Razak, A. R. A., Haines, C., Lee, C. M., Douglas, S. F., Wang, L. E., Siu, L. L., Tannock, I. F., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0159-5 · Cited by 58
Wang, Y., Zaitsev, K., Lu, Q., Li, S., Schaiff, W. T., Kim, K.-W., Droit, L., Wilen, C. B., Desai, C., Balce, D. R., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-019-0633-0 · Cited by 52
Hansen, A. R., Tannock, I. F., Templeton, A. J., Chen, E. X., Evans, A., Knox, J. J., Prawira, A., Sridhar, S. S., Tan, S., Vera-Badillo, F., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0621 · Cited by 46
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors
Mehnert, J. M., Kaveney, A. D., Malhotra, J. D., Spencer, K. R., Portal, D. E., Goodin, S., Tan, A. R., Aisner, J., Moss, R. A., Lin, H., et al. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03919-x · Cited by 36
García-Fernández, M., Karras, P., Checinska, A., Cañón, E., Calvo, G. T., Gómez-López, G., Cifdaloz, M., Colmenar, A., Espinosa-Hevia, L., Olmeda, D., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1199301 · Cited by 35
Kang, M., Lee, K. H., Lee, H.-J., Jeong, C. W., Kwak, C. H., Kim, H. C., & Ku, J. H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020321 · Cited by 35
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationAutophagy and autophagy-related pathways in cancer
Debnath, J., Gammoh, N., & Ryan, K. M. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00585-z · Cited by 1,403
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Gao, W., Wang, X., Zhou, Y., Wang, X., & Yu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01046-3 · Cited by 1,042
Oxidative cell death in cancer: mechanisms and therapeutic opportunities
An, X., Yu, W., Liu, J., Tang, D., Yang, L., & Chen, X. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-06939-5 · Cited by 523
Programmed Cell Death Tunes Tumor Immunity
Liu, J., Hong, M., Li, Y., Chen, D., Wu, Y., & Hu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847345 · Cited by 316
Metadata
- Authors
- Xia, H., Green, D. R., & Zou, W.
- Venue
- Nature Reviews Cancer
- Published
- 2021-03-23
- Volume
- 21
- Issue
- 5
- Pages
- 281-297
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W3136819448
- Cited by
- 404
- References
- 206
- FWCI
- 15.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.